Who Wants To Live Forever? Forging A Regulatory Pathway For Longevity Drugs
Researchers Are Brainstorming Pathways To FDA Approval For An Anti-Aging Indication
Executive Summary
Despite the growing interest, both in and outside of the biotech space, in the so-called ‘longevity’ industry, no regulatory pathway exists to market a drug with a purely geroprotective indication.